Referanser
Agarwal, J. P., Nemade, B., Murthy, V., Ghosh-Laskar, S., Budrukkar, A., Gupta, T., D'Cruz, A., Pai, P., ... Dinshaw, K. (2008). Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiotherapy and Oncology, 89(1), 51-6.
Ahn, P. H., Mitra, N., Alonso-Basanta, M., Palmer, J. N., Adappa, N. D., O'Malley, B. W. ,. J., Rassekh, C., Chalian, A., ... Lin, A. (2016). Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncologica, 55(9-10), 1107-1114.
Akbaba, S., Lang, K., Held, T., Herfarth, K., Rieber, J., Plinkert, P., Auffarth, G. U., Rieken, S., ... Adeberg, S. (2019). Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety. Cancer Management and Research, 11, 1155-1166.
Al-Bulushi, N. K., & Abouzied, M. E. (2016). Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Nuclear Medicine Communications, 37(6), 583-8.
Al-Mamgani, A., van Rooij, P., Mehilal, R., Tans, L., & Levendag, P. C. (2013). Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. European Archives of Oto-Rhino-Laryngology, 270(1), 293-9.
Ambrosch, P. (2007). The role of laser microsurgery in the treatment of laryngeal cancer. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 82-8.
American Cancer Society (9. oktober 2018). Merkel Cell Carcinoma Stages. [nettdokument]. Atlanta, GA: American Cancer Society. Hentet 17. desember 2018 fra https://www.cancer.org/cancer/merkel-cell-skin-cancer/detection-diagnosis-staging/staging.html
Amit, M., Abdelmeguid, A. S., Watcherporn, T., Takahashi, H., Tam, S., Bell, D., Ferrarotto, R., Glisson, B., ... Hanna, E. Y. (2019). Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. Journal of Clinical Oncology, 37(6), 504-512.
Amols, H. I., Lagueux, B., & Cagna, D. (1986). Radiobiological effectiveness (RBE) of megavoltage X-ray and electron beams in radiotherapy. Radiation Research, 105(1), 58-67.
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tan, P. F., Westra, W. H., Chung, C. H., ... Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine, 363(1), 24-35.
Arunachalam, P. S., Putnam, G., Jennings, P., Messersmith, R., & Robson, A. K. (2002). Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers. Clinical Otolaryngology and Allied Sciences, 27(5), 409-11.
Arya, S., Rane, P., & Deshmukh, A. (2014). Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clinical Radiology, 69(9), 916-30.
Avdeling for funksjonsvurdering (30. august 2022). Spise- og svelgevansker - vurderingsopphold. [nettside]. Bjørnemyr: Sunnaas sykehus. Hentet 2. mai 2023 fra https://www.sunnaas.no/behandlinger/spise-og-svelgvansker-vurderingsopphold
Bakst, R. L., Su, W., Ozbek, U., Knoll, M. A., Miles, B. A., Gupta, V., & Rhome, R. (2017). Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis. Advances in radiation oncology, 2(2), 159-166.
Bataini, J. P., Bernier, J., Asselain, B., Lave, C., Jaulerry, C., Brunin, F., & Pontvert, D. (1988). Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. International Journal of Radiation Oncology, Biology, Physics, 14(4), 635-42.
Becker, M., Zbären, P., Casselman, J. W., Kohler, R., Dulguerov, P., & Becker, C. D. (2008). Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology, 249(2), 551-9.
Bentz, B. G., Bilsky, M. H., Shah, J. P., & Kraus, D. (2003). Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head and Neck, 25(7), 515-20.
Bentzen, J. D., & Hansen, H. S. (2007). Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region. Head and Neck, 29(1), 47-51.
Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M., Jacobs, J. R., ... Lefebvre, J. L. (2005). Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head and Neck, 27(10), 843-50.
Bhattacharyya, N., & Fried, M. P. (2002). Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Archives of Otolaryngology - Head and Neck Surgery, 128(8), 904-8.
Biau, J., Lapeyre, M., Troussier, I., Budach, W., Giralt, J., Grau, C., Kazmierska, J., Langendijk, J. A., ... Gregoire, V. (2019). Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiotherapy and Oncology, 134, 1-9.
Binazzi, A., Ferrante, P., & Marinaccio, A. (2015). Occupational exposure and sinonasal cancer: a systematic review and meta-analysis. BMC Cancer, 15, 49.
Blanchard, P., Bourhis, J., Lacas, B., Posner, M. R., Vermorken, J. B., Cruz Hernandez, J. J., Bourredjem, A., Calais, G., ... Pignon, J. P. (2013). Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. Journal of Clinical Oncology, 31(23), 2854-60.
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., ... Ang, K. K. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 354(6), 567-78.
Boscolo-Rizzo, P., Schroeder, L., Romeo, S., & Pawlita, M. (2015). The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clinical and Experimental Metastasis, 32(8), 835-45.
Bossi, P., Saba, N. F., Vermorken, J. B., Strojan, P., Pala, L., de Bree, R., Rodrigo, J. P., Lopez, F., ... Ferlito, A. (2015). The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treatment Reviews, 41(10), 836-43.
Bossi, P., Saba, N. F., Vermorken, J. B., Strojan, P., Pala, L., de Bree, R., Rodrigo, J. P., Lopez, F., ... Ferlito, A. (2015). The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treatment Reviews, 41(10), 836-43.
Brady, L. W., Perez, C. A. (1998). Principles and practice of radiation oncology. Lippincott-Ravens.
Brandstorp-Boesen, J., Falk, R. S., Boysen, M., & Brøndbo, K. (2014). Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center. European Archives of Oto-Rhino-Laryngology, 271(12), 3233-9.
Brandstorp-Boesen, J., Sørum Falk, R., Boysen, M., & Brøndbo, K. (2017). Impact of stage, management and recurrence on survival rates in laryngeal cancer. PloS One, 12(7), e0179371.
Brandstorp-Boesen, J., Sørum Falk, R., Folkvard Evensen, J., Boysen, M., & Brøndbo, K. (2016). Risk of Recurrence in Laryngeal Cancer. PloS One, 11(10), e0164068.
Breuninger, H., & Dietz, K. (1991). Prediction of subclinical tumor infiltration in basal cell carcinoma. Journal of Dermatologic Surgery and Oncology, 17(7), 574-8.
Brierley, J. D., Gospodarwicz, M. K., Wittekind, C. (2017). TNM : classification of malignant tumours. Wiley-Blackwell.
Brouwer, C. L., Steenbakkers, R. J., Bourhis, J., Budach, W., Grau, C., Gregoire, V., van Herk, M., Lee, A., ... Langendijk, J. A. (2015). CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy and Oncology, 117(1), 83-90.
Brøndbo, K., Boysen, M., & Natvig, K. (1997). Laserkirurgi ved larynxcancer (T1a glottis). Nytt behandlingsalternativ.. Tidsskrift for den Norske Legeforening, 117(28), 4070-1.
Brøndbo, K., Fridrich, K., & Boysen, M. (2007). Laser surgery of T1a glottic carcinomas; significance of resection margins. European Archives of Oto-Rhino-Laryngology, 264(6), 627-30.
Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G. ,. J., Psyrri, A., Basté, N., ... KEYNOTE-048 Investigators (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394(10212), 1915-1928.
Cacicedo, J., Navarro, A., Alongi, F., Gómez de Iturriaga, A., Del Hoyo, O., Boveda, E., Casquero, F., Perez, J. F., & Bilbao, P. (2014). The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treatment Reviews, 40(1), 178-89.
Candela, F. C., Kothari, K., & Shah, J. P. (1990). Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head and Neck, 12(3), 197-203.
Chambers, K. J., Lehmann, A. E., Remenschneider, A., Dedmon, M., Meier, J., Gray, S. T., & Lin, D. T. (2015). Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. Journal of neurological surgery. Part B, Skull base, 76(2), 94-100.
Chambers, K. J., Lehmann, A. E., Remenschneider, A., Dedmon, M., Meier, J., Gray, S. T., & Lin, D. T. (2015). Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. Journal of neurological surgery. Part B, Skull base, 76(2), 94-100.
Chan, A. W. (2011-2024). Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy [pågående studie]. (NCT01586767). Hentet fra https://www.clinicaltrials.gov/study/NCT01586767
Chen, A. M., Bucci, M. K., Quivey, J. M., Garcia, J., Eisele, D. W., & Fu, K. K. (2006). Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. International Journal of Radiation Oncology, Biology, Physics, 66(4), 1044-50.
Chen, A. M., Farwell, D. G., Luu, Q., Cheng, S., Donald, P. J., & Purdy, J. A. (2011). Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 80(3), 669-76.
Cheraghlou, S., Torabi, S. J., Husain, Z. A., Otremba, M. D., Osborn, H. A., Mehra, S., Yarbrough, W. G., Burtness, B. A., & Judson, B. L. (2019). HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. Laryngoscope, 129(3), 684-691.
Cheung, R. L., Russell, A. C., & Freeman, J. (2008). Does routine preoperative imaging of parotid tumours affect surgical management decision making?. J Otolaryngol Head and Neck Surg, 37(3), 430-4.
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., ... Perou, C. M. (2004). Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell, 5(5), 489-500.
Cianchetti, M., Mancuso, A. A., Amdur, R. J., Werning, J. W., Kirwan, J., Morris, C. G., & Mendenhall, W. M. (2009). Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope, 119(12), 2348-54.
Clark, R. R., Soutar, D. S., & Hunter, K. D. (2010). A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology, 57(1), 138-46.
Cohen, E. E. W., Soulières, D., Le Tourneau, C., Dinis, J., Licitra, L., Ahn, M. J., Soria, A., Machiels, J. P., ... KEYNOTE-040 investigators (2019). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet, 393(10167), 156-167.
Cohen, R. B., Delord, J. P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., ... Keam, B. (2018). Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study. American Journal of Clinical Oncology, 41(11), 1083-1088.
Colevas, A. D. (2006). Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 24(17), 2644-52.
Colevas, A. D. (2015). Systemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of the National Comprehensive Cancer Network, 13(5), e37-48.
Collins, B., Abernethy, J., Barnes, L. (2010). Oral Malignant Melanoma. [nettdokument]. Newport Beach, Ca: Oral Cancer Foundation. Hentet 22. februar 2018 fra https://oralcancerfoundation.org/facts/rare/oral-malignant-melanoma/
Copper, M. P., Jovanovic, A., Nauta, J. J., Braakhuis, B. J., de Vries, N., van der Waal, I., & Snow, G. B. (1995). Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery, 121(2), 157-60.
Corrêa, T. S., Matos, G. D. R., Segura, M., & Dos Anjos, C. H. (2018). Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab. Case Reports in Oncology, 11(2), 252-257.
Corry, J., Peters, L. J., Costa, I. D., Milner, A. D., Fawns, H., Rischin, D., & Porceddu, S. (2005). The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiotherapy and Oncology, 77(2), 137-42.
Corvo, R. (2007). Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 85(1), 156-70.
Cowey, C. L. (2013). Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. Dermatology and therapy, 3(1), 17-31.
DAHANCA (2016). Behandling af planocellulært karcinom i mundhulen: nationale retningslinjer (3 utg.) Aarhus: DAHANCA.
DAHANCA (2018). Danish Head and Neck Cancer Group. [nettside]. Aarhus: DAHANCA. Hentet 14. februar 2018 fra https://www.dahanca.oncology.dk/
DAHANCA (2018). DAHANCA Radiotherapy Guidelines Aarhus: DAHANCA.
DAHANCA (2021). Radiotherapy Guidelines 2020 [s.l.]: Danish Head and Neck cancer Study Group. Hentet fra https://dahanca.dk/uploads/TilFagfolk/Guideline/GUID_DAHANCA_Radiotherapy_guidelines_2020.pdf
DAHANCA (u.å.). DAHANCA 25 studierne – Styrketræning til hoved-halscancer patienter Aarhus: DAHANCA. Hentet fra https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Styrketraening-tilhoved-halscancer.pdf
Dale, E., Moan, J. M., Osnes, T. A., & Bogsrud, T. V. (2017). Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome. European Archives of Oto-Rhino-Laryngology, 274(2), 1015-1019.
Dammann, F., Horger, M., Mueller-Berg, M., Schlemmer, H., Claussen, C. D., Hoffman, J., Eschmann, S., & Bares, R. (2005). Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR: American Journal of Roentgenology, 184(4), 1326-31.
Danish Head and Neck Cancer Group (2016-2023). DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC [pågående studie]. (NCT02661152). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02661152
de Bondt, R. B., Nelemans, P. J., Hofman, P. A., Casselman, J. W., Kremer, B., van Engelshoven, J. M., & Beets-Tan, R. G. (2007). Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. European Journal of Radiology, 64(2), 266-72.
de Bree, R., Deurloo, E. E., Snow, G. B., & Leemans, C. R. (2000). Screening for distant metastases in patients with head and neck cancer. Laryngoscope, 110(3 Pt 1), 397-401.
De Crevoisier, R., Bourhis, J., Domenge, C., Wibault, P., Koscielny, S., Lusinchi, A., Mamelle, G., Janot, F., ... Eschwege, F. (1998). Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. Journal of Clinical Oncology, 16(11), 3556-62.
DeConti, R. C. (2012). Chemotherapy of squamous cell carcinoma of the skin. Seminars in Oncology, 39(2), 145-9.
DeConti, R. C., & Schoenfeld, D. (1981). A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer, 48(5), 1061-72.
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., ... Demetri, G. D. (2020). Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncology, 21(2), 271-282.
DSHHO, DAHANCA (2017). Kræft i næse og bihuler: nationale retningslinjer for udredning, behandling og rehabilitering af patienter med maligne tumorer i cavum nasi, de paranasale bihuler og vestibulum nasi Aarhus: Dansk Selskab for Hoved- og Hals Onkologi (DSHHO) og Dansk Hoved-hals Cancer Gruppe (DAHANCA).
Dulguerov, P., Allal, A. S., & Calcaterra, T. C. (2001). Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncology, 2(11), 683-90.
Duprez, F., Berwouts, D., Madani, I., Bonte, K., Boterberg, T., De Gersem, W., Deron, P., Huvenne, W., & De Neve, W. (2014). High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity. Radiotherapy and Oncology, 111(3), 388-92.
El-Naggar, A. K., Chan, J. K. C., Grandis, J. R., Slootweg, P. J. (2017). WHO classification of head and neck tumors. International Agency for Research on Cancer.
Eloy, J. A., Vivero, R. J., Hoang, K., Civantos, F. J., Weed, D. T., Morcos, J. J., & Casiano, R. R. (2009). Comparison of transnasal endoscopic and open craniofacial resection for malignant tumors of the anterior skull base. Laryngoscope, 119(5), 834-40.
Fakhry, N., Santini, L., Lagier, A., Dessi, P., & Giovanni, A. (2014). Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. International Journal of Oral and Maxillofacial Surgery, 43(7), 802-5.
Faquin, W. C., Rossi, E. D., Baloch, Z., Barkan, G. A., Foschini, M. P., Kurtycz, D. F. J., ... Pusztaszeri, M. (2018). The Milan System for Reporting Salivary Gland Cytopathology. Springer.
Ferris, R. L. (2015). Immunology and Immunotherapy of Head and Neck Cancer. Journal of Clinical Oncology, 33(29), 3293-304.
Foulkes, W. D., Brunet, J. S., Sieh, W., Black, M. J., Shenouda, G., & Narod, S. A. (1996). Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ, 313(7059), 716-21.
Frank, S. J., Rosenthal, D. I., Petsuksiri, J., Ang, K. K., Morrison, W. H., Weber, R. S., Glisson, B. S., Chao, K. S., ... Garden, A. S. (2010). Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. International Journal of Radiation Oncology, Biology, Physics, 78(4), 1005-10.
Frierson, H. F. ,. J., Mills, S. E., Fechner, R. E., Taxy, J. B., & Levine, P. A. (1986). Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. American Journal of Surgical Pathology, 10(11), 771-9.
Fujimoto, R., Higashi, T., Nakamoto, Y., Hara, T., Lyshchik, A., Ishizu, K., Kawashima, H., Kawase, S., ... Togashi, K. (2006). Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Annals of Nuclear Medicine, 20(6), 399-408.
Furness, S., Glenny, A. M., Worthington, H. V., Pavitt, S., Oliver, R., Clarkson, J. E., Macluskey, M., Chan, K. K., & Conway, D. I. (2011). Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. The Cochrane database of systematic reviews, (4), CD006386.
Fushimi, C., Tada, Y., Takahashi, H., Nagao, T., Ojiri, H., Masubuchi, T., Matsuki, T., Miura, K., ... Saotome, T. (2018). A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Annals of Oncology, 29(4), 979-984.
Galloway, T., Amdur, R. (2016). Management of late complications of head and neck cancer and its treatment. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016
Ganti, A. K., & Kessinger, A. (2011). Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treatment Reviews, 37(6), 440-3.
Gebre-Medhin, M., Brun, E., Engström, P., Haugen Cange, H., Hammarstedt-Nordenvall, L., Reizenstein, J., Nyman, J., Abel, E., ... Nilsson, P. (2021). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology, 39(1), 38-47.
Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., Glastonbury, C., Kaufman, M., ... Ha, P. (2021). Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology, 39(17), 1909-1941.
Gilbert, J., Murphy, B. A., Jackson, L. (2016). Health-related quality of life in head and neck cancer. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016
Glisson, B. S., Murphy, B. A., Frenette, G., Khuri, F. R., & Forastiere, A. A. (2002). Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 20(6), 1593-9.
Govers, T. M., Hannink, G., Merkx, M. A., Takes, R. P., & Rovers, M. M. (2013). Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncology, 49(8), 726-32.
Grau, C., Johansen, L. V., Jakobsen, J., Geertsen, P., Andersen, E., & Jensen, B. B. (2000). Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiotherapy and Oncology, 55(2), 121-9.
Gray, S. T., Herr, M. W., Sethi, R. K., Diercks, G., Lee, L., Curry, W., Chan, A., Clark, J., ... Lin, D. T. (2015). Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head and Neck, 37(3), 366-74.
Gregoire, V., Ang, K., Budach, W., Grau, C., Hamoir, M., Langendijk, J. A., Lee, A., Le, Q. T., ... Lengele, B. (2014). Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology, 110(1), 172-81.
Grégoire, V., Evans, M., Le, Q. T., Bourhis, J., Budach, V., Chen, A., Eisbruch, A., Feng, M., ... Grau, C. (2018). Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy and Oncology, 126(1), 3-24.
Guan, J., Li, Q., Zhang, Y., Xiao, N., Chen, M., Zhang, Y., Li, L., & Chen, L. (2016). A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN). Oncotarget, 7(6), 7110-9.
Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A., Ronchin, P., ... Pivot, X. (2004). Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. European Journal of Cancer, 40(14), 2071-6.
Guigay, J., Fayette, J., Mesia, R., Lafond, C., Saada-Bouzid, E., Geoffrois, L., Martin, L., Cupissol, D., ... Auperin, A. (2019). TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Journal of Clinical Oncology, 37(15_suppl), 6002.
Hamauchi, S., Yokota, T., Onozawa, Y., Ogawa, H., Onoe, T., Kamijo, T., Iida, Y., Nishimura, T., ... Yasui, H. (2015). Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Jpn Journal of Clinical Oncology, 45(12), 1116-21.
Hanna, E. Y. (2008-2023). Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer [pågående studie]. (NCT00707473). Hentet fra https://www.clinicaltrials.gov/study/NCT00707473
Hannisdal, K., Boysen, M., & Evensen, J. F. (2003). Different prognostic indices in 310 patients with tonsillar carcinomas. Head and Neck, 25(2), 123-31.
Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., & Osato, T. (1990). Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335(8682), 128-30.
Harrington, K. J., Ferris, R. L., Blumenschein, G. ,. J., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., ... Guigay, J. (2017). Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncology, 18(8), 1104-1115.
Hashibe, M., Brennan, P., Chuang, S. C., Boccia, S., Castellsague, X., Chen, C., Curado, M. P., Dal Maso, L., ... Boffetta, P. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 541-50.
Hassan Metwally, M. A., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Iqbal, K., Prasad, R., Grau, C., & Overgaard, J. (2015). IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 116(1), 15-20.
Haughey, B. H., Gates, G. A., Arfken, C. L., & Harvey, J. (1992). Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Annals of Otology, Rhinology and Laryngology, 101(2 Pt 1), 105-12.
Hayashi, K., Koto, M., Demizu, Y., Saitoh, J. I., Suefuji, H., Okimoto, T., Ohno, T., Shioyama, Y., ... Kamada, T. (2018). A retrospective multicenter study of carbon-ion radiotherapy for major salivary gland carcinomas: Subanalysis of J-CROS 1402 HN. Cancer Science, 109(5), 1576-1582.
Helse- og omsorgsdepartementet (2006). Nasjonal helseplan (2007-2010) Oslo: Hentet fra http://www.regjeringen.no/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf
Helse- og omsorgsdepartementet (2006). Nasjonal strategi for kreftområdet 2006-2009 Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/hod/sykehus/kreftstrategi-2006-2009.pdf
Helse- og omsorgsdepartementet (2013). Sammen - mot kreft: nasjonal kreftstrategi 2013-2017 Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.iccp-portal.org/system/files/plans/kreftstrategien_2013.pdf
Helse- og omsorgsdepartementet (2018). Leve med kreft: nasjonal kreftstrategi (2018-2022) Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/contentassets/266bf1eec38940888a589ec86d79da20/regjeringens_kreftstrategi_180418.pdf
Helsedirektoratet (14. oktober 2019). Palliasjon i kreftomsorgen – handlingsprogram: nasjonal faglig retningslinje. [nettdokument]. Oslo: Helsedirektoratet. Hentet 2. mai 2023 fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-i-kreftomsorgen-handlingsprogram
Helsedirektoratet (22. mai 2020). Maligne melanomer – handlingsprogram: nasjonal faglig retningslinje. [nettdokument]. Oslo: Helsedirektoratet. Hentet 10. mai 2023 fra https://www.helsedirektoratet.no/retningslinjer/maligne-melanomer-handlingsprogram
Helsedirektoratet (2020). Seneffekter etter kreftbehandling: rapport (IS-2872). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/publikasjoner/seneffekter-etter-kreft
Hitt, R., Irigoyen, A., Cortes-Funes, H., Grau, J. J., Garcia-Saenz, J. A., & Cruz-Hernandez, J. J. (2012). Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Annals of Oncology, 23(4), 1016-22.
Ho, A. L., Foster, N. R., Zoroufy, A. J., Campbell, J. D., Worden, F., Price, K., Adkins, D., Bowles, D. W., ... Schwartz, G. K. (2022). Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of Clinical Oncology, 40(36), 4240-4249.
Ho, F. C., Tham, I. W., Earnest, A., Lee, K. M., & Lu, J. J. (2012). Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer, 12, 98.
Holmes, B. J., & Wenig, B. M. (2019). Virus-associated carcinomas of the head & neck: Update from the 2017 WHO classification. Annals of Diagnostic Pathology, 38, 29-42.
Howard, D. J., Lund, V. J., & Wei, W. I. (2006). Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head and Neck, 28(10), 867-73.
Huang, S. H., Waldron, J., Bratman, S. V., Su, J., Kim, J., Bayley, A., Cho, J., Giuliani, M., ... O'Sullivan, B. (2017). Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. International Journal of Radiation Oncology, Biology, Physics, 98(1), 159-169.
Hughes, B. G. M., Munoz-Couselo, E., Mortier, L., Bratland, Å., Gutzmer, R., Roshdy, O., González Mendoza, R., Schachter, J., ... Grob, J. J. (2021). Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial. Annals of Oncology, 32(10), 1276-1285.
Iannetti, G., Valentini, V., Rinna, C., Ventucci, E., & Marianetti, T. M. (2005). Ethmoido-orbital tumors: our experience. Journal of Craniofacial Surgery, 16(6), 1085-91.
Isles, M. G., McConkey, C., & Mehanna, H. M. (2008). A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clinical Otolaryngology, 33(3), 210-22.
Jacinto, J. K. M., Huang, S. H., Su, J., Kim, J., O'Sullivan, B., Ringash, J., Cho, J., Hope, A. J., ... Waldron, J. (2021). Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 111(3, Supplement), e384-e385.
Kaanders, J. H., Hordijk, G. J., & Dutch Cooperative Head and Neck Oncology Group (2002). Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiotherapy and Oncology, 63(3), 299-307.
Kato, H., Kanematsu, M., Watanabe, H., Mizuta, K., & Aoki, M. (2014). Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology, 56(9), 789-95.
Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D'Angelo, S. P., Shih, K. C., Lebbe, C., ... Nghiem, P. (2016). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncology, 17(10), 1374-1385.
Khan, L., Choo, R., Breen, D., Assaad, D., Fialkov, J., Antonyshyn, O., McKenzie, D., Woo, T., ... Barnes, E. (2012). Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiotherapy and Oncology, 104(2), 263-6.
Kim, B. S., Vongtama, R., & Juillard, G. (2004). Sinonasal undifferentiated carcinoma: case series and literature review. American Journal of Otolaryngology, 25(3), 162-6.
Kim, Y. S. (2017). Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence. Radiation oncology journal, 35(1), 1-15.
King, A. D., Ahuja, A. T., Leung, S. F., Lam, W. W., Teo, P., Chan, Y. L., & Metreweli, C. (2000). Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head and Neck, 22(3), 275-81.
Kirkpatrick, J. P., van der Kogel, A. J., & Schultheiss, T. E. (2010). Radiation dose-volume effects in the spinal cord. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S42-9.
Kiyota, N., Tahara, M., Mizusawa, J., Kodaira, T., Fujii, H., Yamazaki, T., Mitani, H., Iwae, S., ... Hayashi, R. (2022). Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial. Journal of Clinical Oncology, 40(18), 1980-1990.
Kolk, A., Wolff, K. D., Smeets, R., Kesting, M., Hein, R., & Eckert, A. W. (2014). Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options. Cancer Treatment Reviews, 40(7), 819-37.
König, M., Osnes, T., Jebsen, P., Evensen, J. F., & Meling, T. R. (2018). Olfactory neuroblastoma: a single-center experience. Neurosurgical Review, 41(1), 323-331.
König, M., Osnes, T., Jebsen, P., & Meling, T. R. (2018). Craniofacial resection of malignant tumors of the anterior skull base: a case series and a systematic review. Acta Neurochirurgica, 160(12), 2339-2348.
Koto, M., Demizu, Y., Saitoh, J. I., Suefuji, H., Tsuji, H., Okimoto, T., Ohno, T., Shioyama, Y., ... Kamada, T. (2017). Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology, Biology, Physics, 97(5), 1054-1060.
Krämer, A., Bochtler, T., Pauli, C., Baciarello, G., Delorme, S., Hemminki, K., Mileshkin, L., Moch, H., ... Fizazi, K. (2023). Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(3), 228-246.
Kwon, M., Roh, J. L., Lee, J., Cho, K. J., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2015). Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. Journal of Cranio-Maxillo-Facial Surgery, 43(6), 769-78.
Kyzas, P. A., Evangelou, E., Denaxa-Kyza, D., & Ioannidis, J. P. (2008). 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Journal of the National Cancer Institute, 100(10), 712-20.
Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., Zackrisson, B., Szutkowski, Z., ... Blanchard, P. (2017). Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncology, 18(9), 1221-1237.
Lagha, A., Chraiet, N., Ayadi, M., Krimi, S., Allani, B., Rifi, H., Raies, H., & Mezlini, A. (2012). Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head & Neck Oncology, 4, 19.
Lambrecht, M., Eekers, D. B. P., Alapetite, C., Burnet, N. G., Calugaru, V., Coremans, I. E. M., Fossati, P., Hoyer, M., ... Troost, E. G. C. (2018). Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Radiotherapy and Oncology, 128(1), 26-36.
Langerman, A., Plein, C., Vokes, E. E., Salama, J. K., Haraf, D. J., Blair, E. A., & Stenson, K. M. (2009). Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. Archives of Otolaryngology - Head and Neck Surgery, 135(11), 1133-6.
Larsen, I. K. (2015). Cancer in Norway 2014: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.
Larsen, I. K. (2017). Cancer in Norway 2016: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.
Larsen, I. K. (2022). Cancer in Norway 2021: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.
Lee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., Corry, J., Grau, C., ... Wee, J. T. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and Oncology, 126(1), 25-36.
Lee, J. R., Kim, J. S., Roh, J. L., Lee, J. H., Baek, J. H., Cho, K. J., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2015). Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study. Radiology, 274(3), 764-71.
Lee, Y. Y., Wong, K. T., King, A. D., & Ahuja, A. T. (2008). Imaging of salivary gland tumours. European Journal of Radiology, 66(3), 419-36.
Leong, S. P. (2011). Role of selective sentinel lymph node dissection in head and neck melanoma. Journal of Surgical Oncology, 104(4), 361-8.
Leslie, A., Fyfe, E., Guest, P., Goddard, P., & Kabala, J. E. (1999). Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging. Journal of Computer Assisted Tomography, 23(1), 43-9.
Levernes, S. (2019). Faglige anbefalinger for nomenklatur for volumer i stråleterapi (Teknisk dokument nummer 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/2f7317b7-e2f3-423e-b388-7d1d8d07b271:e947e054b123c9af0fa0fae10c867ce43e3d149e/TekniskDokument14.pdf
Lewis, J. S. ,. J., Beadle, B., Bishop, J. A., Chernock, R. D., Colasacco, C., Lacchetti, C., Moncur, J. T., Rocco, J. W., ... Faquin, W. C. (2018). Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Archives of Pathology and Laboratory Medicine, 142(5), 559-597.
Li, H., Torabi, S. J., Yarbrough, W. G., Mehra, S., Osborn, H. A., & Judson, B. (2018). Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA otolaryngology-- head & neck surgery, 144(6), 519-525.
Liao, L. J., Lo, W. C., Hsu, W. L., Wang, C. T., & Lai, M. S. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer, 12, 236.
Licitra, L., Nicolai, P., Calstelnuovo, P., Benazzo, M., Deantonio, L. (2013-2024). Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients [pågående studie]. (NCT02099188). Hentet fra https://www.clinicaltrials.gov/study/NCT02099188
Licitra, L., Nicolai, P., Calstelnuovo, P., Benazzo, M., Sponghini, A. (2013-2024). Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients [pågående studie]. (NCT02099175). Hentet fra https://www.clinicaltrials.gov/study/NCT02099175
Lindberg, R. (1972). Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 29(6), 1446-9.
Loevner, L. A., & Sonners, A. I. (2002). Imaging of neoplasms of the paranasal sinuses. Magnetic Resonance Imaging Clinics of North America, 10(3), 467-93.
Lonneux, M., Hamoir, M., Reychler, H., Maingon, P., Duvillard, C., Calais, G., Bridji, B., Digue, L., ... Gregoire, V. (2010). Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. Journal of Clinical Oncology, 28(7), 1190-5.
Lopez, F., Suárez, V., Vivanco, B., Suarez, C., & Llorente, J. L. (2015). Current management of sinonasal undifferentiated carcinoma. Rhinology, 53(3), 212-20.
López, F., Rodrigo, J. P., Silver, C. E., Haigentz, M. ,. J., Bishop, J. A., Strojan, P., Hartl, D. M., Bradley, P. J., ... Ferlito, A. (2016). Cervical lymph node metastases from remote primary tumor sites. Head and Neck, 38 Suppl 1, E2374-85.
Loree, J. T., Popat, S. R., Burke, M. S., Frustino, J., Grewal, J. S., & Loree, T. R. (2019). Sentinel lymph node biopsy for management of the N0 neck in oral cavity squamous cell carcinoma. Journal of Surgical Oncology, 120(2), 101-108.
Lund, V. J., Clarke, P. M., Swift, A. C., McGarry, G. W., Kerawala, C., & Carnell, D. (2016). Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. Journal of Laryngology and Otology, 130(S2), S111-s118.
Lydiatt, W. M., Patel, S. G., O'Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., Loomis, A. M., & Shah, J. P. (2017). Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians, 67(2), 122-137.
Maare, C., Kjeldsen, R., Jensen, K., Andersen, M., Andersen, E., & Johansen, J. (2014). PO-0666: High dose hypofractionated radiotherapy for treatment and palliation of head and neck cancer patients. Radiotherapy and Oncology, 111(Suppl 1), S8.
Machiels, J. P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020). Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 31(11), 1462-1475.
Maghami, E., Ismaila, N., Alvarez, A., Chernock, R., Duvvuri, U., Geiger, J., Gross, N., Haughey, B., ... Caudell, J. (2020). Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. Journal of Clinical Oncology, 38(22), 2570-2596.
Mahler, V., Boysen, M., & Brøndbo, K. (2010). Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?. European Archives of Oto-Rhino-Laryngology, 267(5), 743-50.
Mahmood, U., Koshy, M., Goloubeva, O., & Suntharalingam, M. (2011). Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors. Archives of Otolaryngology - Head and Neck Surgery, 137(10), 1025-30.
Martin, J. M., & Galloway, T. J. (2015). Evaluation and management of head and neck squamous cell carcinoma of unknown primary. Surgical Oncology Clinics of North America, 24(3), 579-91.
Maubec, E., Petrow, P., Scheer-Senyarich, I., Duvillard, P., Lacroix, L., Gelly, J., Certain, A., Duval, X., ... Avril, M. F. (2011). Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. Journal of Clinical Oncology, 29(25), 3419-26.
Meites, E., Stone, L., Amiling, R., Singh, V., Unger, E. R., Derkay, C. S., & Markowitz, L. E. (2021). Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States. Clinical Infectious Diseases, 73(5), 885-890.
Mendenhall, W. M., Morris, C. G., Amdur, R. J., Werning, J. W., & Villaret, D. B. (2005). Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer, 103(12), 2544-50.
Merck Sharp & Dohme LLC (2017-2023). Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) [pågående studie]. (NCT03284424). Hentet fra https://www.clinicaltrials.gov/study/NCT03284424
Merino, O. R., Lindberg, R. D., & Fletcher, G. H. (1977). An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 40(1), 145-51.
Migden, M. R., Rischin, D., Schmults, C. D., Guminski, A., Hauschild, A., Lewis, K. D., Chung, C. H., Hernandez-Aya, L., ... Fury, M. G. (2018). PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine, 379(4), 341-351.
Mourad, W. F., Hauerstock, D., Shourbaji, R. A., Hu, K. S., Culliney, B., Li, Z., Jacobson, A., Tran, T., ... Harrison, L. B. (2013). Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. American Journal of Clinical Oncology, 36(6), 584-8.
Müller von der Grün, J., Tahtali, A., Ghanaati, S., Rödel, C., & Balermpas, P. (2017). Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site – current status and challenges. Radiation Oncology, 12(1), 82.
Näsman, A., Attner, P., Hammarstedt, L., Du, J., Eriksson, M., Giraud, G., Ahrlund-Richter, S., Marklund, L., ... Dalianis, T. (2009). Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. International Journal of Cancer, 125(2), 362-6.
NCCN (2015). Head and neck cancers. Version 1.2015 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.
NCCN (2018). Ethmoid sinus tumors; Maxillary sinus. I: Head and neck cancers. Version 2.2018 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.
NCCN (2018). Head and neck cancers. Version 2.2018 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.
Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjose, S., & Trottier, H. (2014). HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncology, 15(12), 1319-31.
NICE (2004). Guidance on cancer services: improving outcomes in head and neck cancers: the manual London: National Institute for Clinical Excellence. Hentet fra https://www.nice.org.uk/guidance/csg6/resources/improving-outcomes-in-head-and-neck-cancers-update-pdf-773377597
Nicolaidou, E., Mikrova, A., Antoniou, C., & Katsambas, A. D. (2012). Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes. British Journal of Dermatology, 166(1), 16-21.
Nishio, N., Fujimoto, Y., Fujii, M., Saito, K., Hiramatsu, M., Maruo, T., Iwami, K., Kamei, Y., ... Nakashima, T. (2015). Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base. Otolaryngology and Head and Neck Surgery, 153(2), 231-8.
NORDCAN group (20. desember 2017). NORDCAN prosjektet. [nettressurs]. Lyon: NORDCAN: Association of the Nordic Cancer Registries. Hentet 14. februar 2018 fra http://www-dep.iarc.fr/nordcan.htm
Noronha, V., Joshi, A., Patil, V. M., Agarwal, J., Laskar, S. G., Budrukkar, A. N., Murthy, V., & Gupta, T. (2017). Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer. Journal of Clinical Oncology, 35(15 suppl), 6007.
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., ... Hall, E. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncology, 12(2), 127-36.
Nyrud, M. K., Bratland, Å., Landrø, L., Brevig, T., Ryder, T., Hermann, R., & Frich, L. (2022). Merkel cell carcinoma. Tidsskrift for den Norske Legeforening, 142(9)
Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998). A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology, 46(2), 135-46.
Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E., Bentzen, J., Bastholt, L., ... Evensen, J. F. (2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet, 362(9388), 933-40.
Ow, T. J., & Myers, J. N. (2011). Current management of advanced resectable oral cavity squamous cell carcinoma. Clinical and Experimental Otorhinolaryngology, 4(1), 1-10.
Patel, S. G., Prasad, M. L., Escrig, M., Singh, B., Shaha, A. R., Kraus, D. H., Boyle, J. O., Huvos, A. G., ... Shah, J. P. (2002). Primary mucosal malignant melanoma of the head and neck. Head and Neck, 24(3), 247-57.
Patel, S. G., Singh, B., Polluri, A., Bridger, P. G., Cantu, G., Cheesman, A. D., deSa, G. M., Donald, P., ... Shah, J. P. (2003). Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer, 98(6), 1179-87.
Patel, S. G., Singh, B., Stambuk, H. E., Carlson, D., Bridger, P. G., Cantu, G., Cheesman, A. D., Donald, P., ... Shah, J. P. (2012). Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. Journal of neurological surgery. Part B, Skull base, 73(3), 208-20.
Patel, S. H., Wang, Z., Wong, W. W., Murad, M. H., Buckey, C. R., Mohammed, K., Alahdab, F., Altayar, O., ... Foote, R. L. (2014). Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncology, 15(9), 1027-38.
Pathak, I., O'Brien, C. J., Petersen-Schaeffer, K., McNeil, E. B., McMahon, J., Quinn, M. J., Thompson, J. F., & McCarthy, W. H. (2001). Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?. Head and Neck, 23(9), 785-90.
Pignon, J. P., Bourhis, J., Domenge, C., & Designé, L. (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 355(9208), 949-55.
Pignon, J. P., le Maître, A., Maillard, E., Bourhis, J., & MACH-NC Collaborative Group (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology, 92(1), 4-14.
Porceddu, S. V., Rosser, B., Burmeister, B. H., Jones, M., Hickey, B., Baumann, K., Gogna, K., Pullar, A., ... Holt, T. (2007). Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". Radiotherapy and Oncology, 85(3), 456-62.
Prowse, S. J., Shaw, R., Ganeshan, D., Prowse, P. M., Hanlon, R., Lewis-Jones, H., & Wieshmann, H. (2013). The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy. Journal of Laryngology and Otology, 127(8), 780-7.
Raghavan, U., Quraishi, S., & Bradley, P. J. (2003). Multiple primary tumors in patients diagnosed with hypopharyngeal cancer. Otolaryngology and Head and Neck Surgery, 128(3), 419-25.
Reiersen, D. A., Pahilan, M. E., & Devaiah, A. K. (2012). Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngology and Head and Neck Surgery, 147(1), 7-14.
Riaz, N., Morris, L. G., Lee, W., & Chan, T. A. (2014). Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes & diseases, 1(1), 75-86.
Roscher, I., Brevig, T., Mørk, G., Helsing, P., & Gjersvik, P. (2011). Mohs’ kirurgi ved basalcellekarsinom i ansiktet. Tidsskrift for den Norske Legeforening, 131(24), 2475-9.
Rusthoven, K. E., Koshy, M., & Paulino, A. C. (2004). The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer, 101(11), 2641-9.
Sakata, K., Maeda, A., Rikimaru, H., Ono, T., Koga, N., Takeshige, N., Tokutomi, T., Umeno, H., ... Morioka, M. (2016). Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management. World Neurosurgery, 89, 240-54.
Saku, T., Hayashi, Y., Takahara, O., Matsuura, H., Tokunaga, M., Tokunaga, M., Tokuoka, S., Soda, M., ... Land, C. E. (1997). Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer, 79(8), 1465-75.
Schneider, A. B., Lubin, J., Ron, E., Abrahams, C., Stovall, M., Goel, A., Shore-Freedman, E., & Gierlowski, T. C. (1998). Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiation Research, 149(6), 625-30.
Schoffski, P., Catimel, G., Planting, A. S., Droz, J. P., Verweij, J., Schrijvers, D., Gras, L., Schrijvers, A., ... Hanauske, A. R. (1999). Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Annals of Oncology, 10(1), 119-22.
Sekretariatet for nye metoder (25. april 2022). Cemiplimab (Libtayo) - Indikasjon II. Nye metoder [nettdokument]. Hamar: Helse Sør-Øst RHF. Hentet 6. juli 2023 fra https://nyemetoder.no/metoder/cemiplimab-libtayo-indikasjon-ii
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., ... Hauschild, A. (2012). Efficacy and safety of vismodegib in advanced basal-cell carcinoma. New England Journal of Medicine, 366(23), 2171-9.
Shahid Iqbal, M., Kelly, C., Kovarik, J., Goranov, B., Shaikh, G., Morgan, D., Dobrowsky, W., & Paleri, V. (2018). Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. Radiotherapy and Oncology, 126(3), 558-567.
Shebl, F. M., Bhatia, K., & Engels, E. A. (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. International Journal of Cancer, 126(10), 2503-8.
Shellock R & D Services, ,. I., Shellock, F. G. (2023). MRIsafety.com: your information resource for MRI safety, bioeffects & patient management. [nettside]. [s.l.]: Shellock R & D Services, Inc. and Frank G. Shelloc. Hentet 27. juni 2023 fra http://www.mrisafety.com/
Sigal, R., Zagdanski, A. M., Schwaab, G., Bosq, J., Auperin, A., Laplanche, A., Francke, J. P., Eschwege, F., ... Vanel, D. (1996). CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics, 16(4), 787-810.
Simon, C., Caballero, C., Gregoire, V., Thurnher, D., Koivunen, P., Ceruse, P., Spriano, G., Nicolai, P., ... René Leemans, C. (2018). Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 "Best of" and 24954 "larynx preservation" study. European Journal of Cancer, 103, 69-77.
Singh, N., Eskander, A., Huang, S. H., Curtin, H., Bartlett, E., Vescan, A., Kraus, D., O'Sullivan, B., ... Yu, E. (2013). Imaging and resectability issues of sinonasal tumors. Expert Review of Anticancer Therapy, 13(3), 297-312.
Skálová, A., Stenman, G., Simpson, R. H. W., Hellquist, H., Slouka, D., Svoboda, T., Bishop, J. A., Hunt, J. L., ... Ferlito, A. (2018). The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. American Journal of Surgical Pathology, 42(2), e11-e27.
Skanjeti, A., Dhomps, A., Paschetta, C., Tordo, J., Delgado Bolton, R. C., & Giammarile, F. (2021). Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer. Seminars in Nuclear Medicine, 51(1), 39-49.
Sobin, L. H., Gospodarwicz, M. K., Wittekind, C. (2010). TNM: classification of malignant tumours. Wiley-Blackwell.
Specht, L., Larsen, S. K., & Hansen, H. S. (2000). Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of Oncology, 11(7), 845-9.
Spencer, S. A., Harris, J., Wheeler, R. H., Machtay, M., Schultz, C., Spanos, W., Rotman, M., Meredith, R., & Ang, K. K. (2008). Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head and Neck, 30(3), 281-8.
Stratigos, A. J., Sekulic, A., Peris, K., Bechter, O., Prey, S., Kaatz, M., Lewis, K. D., Basset-Seguin, N., ... Fury, M. G. (2021). Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncology, 22(6), 848-857.
Strojan, P., Corry, J., Eisbruch, A., Vermorken, J. B., Mendenhall, W. M., Lee, A. W., Haigentz, M. ,. J., Beitler, J. J., ... Ferlito, A. (2015). Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head and Neck, 37(1), 134-50.
Strojan, P., Ferlito, A., Langendijk, J. A., Corry, J., Woolgar, J. A., Rinaldo, A., Silver, C. E., Paleri, V., ... Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head and Neck, 35(2), 286-93.
Strojan, P., Ferlito, A., Medina, J. E., Woolgar, J. A., Rinaldo, A., Robbins, K. T., Fagan, J. J., Mendenhall, W. M., ... Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head and Neck, 35(1), 123-32.
Subbiah, V., Wolf, J., Konda, B., Kang, H., Spira, A., Weiss, J., Takeda, M., Ohe, Y., ... Drilon, A. (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncology, 23(10), 1261-1273.
Sulaiman, N. S., Demizu, Y., Koto, M., Saitoh, J. I., Suefuji, H., Tsuji, H., Ohno, T., Shioyama, Y., ... Kamada, T. (2018). Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology, Biology, Physics, 100(3), 639-646.
Sundhedsstyrelsen (2015). Opfølgningsprogram for hoved- og halskræft København: Sundhedsstyrelsen. Hentet fra https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Opfolgningsprogram_for_hovedhalskraeft_2015.pdf
Szturz, P., Wouters, K., Kiyota, N., Tahara, M., Prabhash, K., Noronha, V., Castro, A., Licitra, L., ... Vermorken, J. B. (2017). Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. Oncologist, 22(9), 1056-1066.
Tajudeen, B. A., Arshi, A., Suh, J. D., St John, M., & Wang, M. B. (2014). Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA otolaryngology-- head & neck surgery, 140(12), 1124-9.
Takahashi, H., Tada, Y., Saotome, T., Akazawa, K., Ojiri, H., Fushimi, C., Masubuchi, T., Matsuki, T., ... Nagao, T. (2019). Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma. Journal of Clinical Oncology, 37(2), 125-134.
Tanzler, E. D., Amdur, R. J., Morris, C. G., Werning, J. W., & Mendenhall, W. M. (2016). Challenging the need for random directed biopsies of the nasopharynx, pyriform sinus, and contralateral tonsil in the workup of unknown primary squamous cell carcinoma of the head and neck. Head and Neck, 38(4), 578-81.
Tchekmedyian, V., Sherman, E. J., Dunn, L., Tran, C., Baxi, S., Katabi, N., Antonescu, C. R., Ostrovnaya, I., ... Ho, A. L. (2019). Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma. Journal of Clinical Oncology, 37(18), 1529-1537.
Telfer, N. R., Colver, G. B., & Morton, C. A. (2008). Guidelines for the management of basal cell carcinoma. British Journal of Dermatology, 159(1), 35-48.
Terhaard, C. H., Lubsen, H., Rasch, C. R., Levendag, P. C., Kaanders, H. H., Tjho-Heslinga, R. E., van Den Ende, P. L., & Burlage, F. (2005). The role of radiotherapy in the treatment of malignant salivary gland tumors. International Journal of Radiation Oncology, Biology, Physics, 61(1), 103-11.
Toustrup, K., Sørensen, B. S., Alsner, J., & Overgaard, J. (2012). Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Seminars in Radiation Oncology, 22(2), 119-27.
Trotta, B. M., Pease, C. S., Rasamny, J. J., Raghavan, P., & Mukherjee, S. (2011). Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics, 31(2), 339-54.
Trotti, A., Harris, J., Gillison, M., Eisbruch, A., Harari, P. M., Adelstein, D. J., Sturgis, E. M., & Galvin, J. M. (2018). NRG-RTOG 1016: Phase III trial comparing radiation/cetuximab to radiation/cisplatin in HPV-related cancer of the oropharynx. International Journal of Radiation Oncology, Biology, Physics, 102(5), 1604-5.
Valstar, M. H., van den Brekel, M. W., & Smeele, L. E. (2010). Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the literature. Head and Neck, 32(10), 1402-11.
van Boxtel, W., Locati, L. D., van Engen-van Grunsven, A. C. H., Bergamini, C., Jonker, M. A., Fiets, E., Cavalieri, S., Tooten, S., ... van Herpen, C. M. L. (2019). Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. European Journal of Cancer, 110, 62-70.
Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., ... Hitt, R. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. New England Journal of Medicine, 359(11), 1116-27.
Vermorken, J. B., Trigo, J., Hitt, R., Koralewski, P., Diaz-Rubio, E., Rolland, F., Knecht, R., Amellal, N., ... Baselga, J. (2007). Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. Journal of Clinical Oncology, 25(16), 2171-7.
Volpe, S., Pepa, M., Zaffaroni, M., Bellerba, F., Santamaria, R., Marvaso, G., Isaksson, L. J., Gandini, S., ... Jereczek-Fossa, B. A. (2021). Machine Learning for Head and Neck Cancer: A Safe Bet?-A Clinically Oriented Systematic Review for the Radiation Oncologist. Frontiers in Oncology, 11, 772663.
von Buchwald, C., & Bradley, P. J. (2007). Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 95-8.
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., ... Low, J. A. (2009). Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. New England Journal of Medicine, 361(12), 1164-72.
Vrionis, F. D., Kienstra, M. A., Rivera, M., & Padhya, T. A. (2004). Malignant tumors of the anterior skull base. Cancer Control, 11(3), 144-51.
Wang, C. C. (1994). To reirradiate or not to reirradiate?. International Journal of Radiation Oncology, Biology, Physics, 29(4), 913; discussion 919.
Wang, T. S., Byrne, P. J., Jacobs, L. K., & Taube, J. M. (2011). Merkel cell carcinoma: update and review. Seminars in Cutaneous Medicine and Surgery, 30(1), 48-56.
Wang, W. Y., Twu, C. W., Chen, H. H., Jiang, R. S., Wu, C. T., Liang, K. L., Shih, Y. T., Chen, C. C., ... Lin, J. C. (2013). Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer, 119(5), 963-70.
Warner, G. C., & Cox, G. J. (2003). Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. Journal of Otolaryngology, 32(2), 107-9.
Watanabe, A., Taniguchi, M., Tsujie, H., Hosokawa, M., Fujita, M., & Sasaki, S. (2009). The value of narrow band imaging for early detection of laryngeal cancer. European Archives of Oto-Rhino-Laryngology, 266(7), 1017-23.
Watkinson, J. C., Clarke, R. W. (2018). Scott-Brown's Otorhinolaryngology and Head and Neck Surgery: Volume 3: Head and Neck Surgery, Plastic Surgery. CRC Press.
Weissman, J. L., & Carrau, R. L. (2001). "Puffed-cheek" CT improves evaluation of the oral cavity. AJNR: American Journal of Neuroradiology, 22(4), 741-4.
WHO Classification of Tumours Editorial Board (Under publisering 2022). WHO classification of head and neck tumors. International Agency for Research on Cancer.
Wong, L. Y., Lam, L. K., Fan, Y. W., Yuen, A. P., & Wei, W. I. (2006). Outcome analysis of patients with craniofacial resection: Hong Kong experience. ANZ Journal of Surgery, 76(5), 313-7.
Wong, S. L., Balch, C. M., Hurley, P., Agarwala, S. S., Akhurst, T. J., Cochran, A., Cormier, J. N., Gorman, M., ... Lyman, G. H. (2012). Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Journal of Clinical Oncology, 30(23), 2912-8.
Wreesmann, V. B., Katabi, N., Palmer, F. L., Montero, P. H., Migliacci, J. C., Gonen, M., Carlson, D., Ganly, I., ... Patel, S. G. (2016). Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head and Neck, 38 Suppl 1, E1192-9.
Wu, J. X., Hanson, M., & Shaha, A. R. (2019). Sentinel node biopsy for cancer of the oral cavity. Journal of Surgical Oncology, 120(2), 99-100.
Wu, L. M., Xu, J. R., Liu, M. J., Zhang, X. F., Hua, J., Zheng, J., & Hu, J. N. (2012). Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis. Academic Radiology, 19(3), 331-40.
Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., Royal, R., & Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. Journal of the National Cancer Institute, 103(2), 129-42.
Xu, J., & Cao, Y. (2014). Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interventional neurology, 2(4), 183-92.
Yeung, A. R., Liauw, S. L., Amdur, R. J., Mancuso, A. A., Hinerman, R. W., Morris, C. G., Villaret, D. B., Werning, J. W., & Mendenhall, W. M. (2008). Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?. Cancer, 112(5), 1076-82.
Yoo, J., Henderson, S., & Walker-Dilks, C. (2013). Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clinical Oncology (Royal College of Radiologists), 25(4), e33-66.
Zhang, Y., Chen, L., Hu, G. Q., Zhang, N., Zhu, X. D., Yang, K. Y., Jin, F., Shi, M., ... Ma, J. (2019). Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. New England Journal of Medicine, 381(12), 1124-1135.
Siste faglige endring: 27. november 2023